Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02122536 · ClinicalTrials.gov registry record · NA
Split-Face Prospective Study Comparing Botox to Xeomin for the Treatment of Facial Wrinkles
A NA study of Facial Wrinkles, sponsored by YMD Eye and Face.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT02122536: Completed NA study of Facial Wrinkles, sponsored by YMD Eye and Face.
NCT02122536 is a NA study of Facial Wrinkles that has completed, run by YMD Eye and Face. The registered enrollment target is 45 participants, below the 80-participant average among 6 other Facial Wrinkles trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02122536, a NA study of Facial Wrinkles, has completed, sponsored by YMD Eye and Face.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this prospective, randomized, double-blind, intraindividual split face study will be to compare onabotulinumtoxinA to incobotulinumtoxinA for the correction of facial wrinkles using a 1:1 dose ratio.
Conditions Studied
Interventions
- DRUG Xeomin to right side of face in half of the subjects; Xeomin to left side of face in the other half of subjects
- DRUG Botox to right side of face in half of the subjects (randomized); Botox to the left side of the face in the other half of subjects
Study Locations (1)
Florida
- Center for Sight - Sarasota
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2012-07 |
| Est. Completion | 2013-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02122536
The ClinicalTrials.gov registry entry for NCT02122536 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 80-participant average among 6 other Facial Wrinkles trials with a reported enrollment target (44% lower). The listed sponsor is YMD Eye and Face, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Facial Wrinkles appearing as the primary indexed condition, and to 2 interventions - of which Xeomin to right side of face in half of the subjects; Xeomin to left side of face in the other half of subjects is the first listed.
NCT02122536 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02122536 about?
NCT02122536 is a clinical study titled "Split-Face Prospective Study Comparing Botox to Xeomin for the Treatment of Facial Wrinkles". The aim of this prospective, randomized, double-blind, intraindividual split face study will be to compare onabotulinumtoxinA to incobotulinumtoxinA for the correction of facial wrinkles using a 1:1 dose ratio.
What is the current status of trial NCT02122536?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2012-07. Estimated completion is 2013-11.
What conditions does trial NCT02122536 study?
This clinical trial studies the following conditions: Facial Wrinkles.
What interventions are being tested in trial NCT02122536?
The interventions under investigation include: Xeomin to right side of face in half of the subjects; Xeomin to left side of face in the other half of subjects (DRUG), Botox to right side of face in half of the subjects (randomized); Botox to the left side of the face in the other half of subjects (DRUG).
Who is sponsoring clinical trial NCT02122536?
This trial is sponsored by YMD Eye and Face, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02122536 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Facial Wrinkles
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PicoWay™ 730 Resolve Fusion for Benign Pigmented Lesions and Wrinkles
COMPLETED · NA
-
Efficacy and Safety Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
COMPLETED · Phase 2
-
Cryo-Touch II for the Treatment of Wrinkles
COMPLETED · Phase 2
-
A Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the Non-FDA Approved Product for the Correction of Nasolabial Folds (NLFs)
COMPLETED · Phase 3
-
Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
COMPLETED · Phase 2
-
A 4-Arm Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults
COMPLETED · Phase 2
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.